MLAB Mesa Laboratories PE ratio, current and historical analysis
- Stocks
- Technology
- NASDAQ: MLAB
- PE Ratio
The current PE ratio of MLAB cannot be calculated, as the latest EPS of -$0.36 is negative. Mesa Laboratories's last PE ratio on record was 616.29 in December 2023.
MLAB PE ratio history
The mean historical PE ratio of Mesa Laboratories over the last ten years is 237.84. Looking back at the last ten years, MLAB's PE ratio peaked in the Mar 2023 quarter at 1,027.82, with a price of $174.73 and an EPS of $0.17. The Mar 2016 quarter marked the lowest point at 31.08, with a price of $96.35 and an EPS of $3.1.
Mesa Laboratories PE ratio by year
Maximum annual increase: 355.38% in 2020
Maximum annual decrease: -31.46% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $118.66 | -$0.36 |
| 2024 | N/A | N/A | $109.73 | -$47.2 |
| 2023 | 1,027.82 | 45.17% | $174.73 | $0.17 |
| 2022 | 708 | 91.9% | $254.88 | $0.36 |
| 2021 | 368.94 | -31.46% | $243.5 | $0.66 |
| 2020 | 538.31 | 355.38% | $226.09 | $0.42 |
| 2019 | 118.21 | N/A | $230.5 | $1.95 |
| 2018 | N/A | N/A | $148.44 | -$0.79 |
| 2017 | 40.36 | 29.86% | $122.7 | $3.04 |
| 2016 | 31.08 | 17.11% | $96.35 | $3.1 |
| 2015 | 26.54 | -23.25% | $72.2 | $2.72 |
| 2014 | 34.58 | 65.14% | $90.25 | $2.61 |
| 2013 | 20.94 | 2.35% | $52.78 | $2.52 |
| 2012 | 20.46 | 35.68% | $49.32 | $2.41 |
| 2011 | 15.08 | -13.43% | $28.8 | $1.91 |
Mesa Laboratories PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $118.66 | -$0.36 |
| Dec 2024 | N/A | N/A | $131.87 | -$46.31 |
| Sep 2024 | N/A | N/A | $129.86 | -$45.61 |
| Jun 2024 | N/A | N/A | $86.77 | -$46.47 |
| Mar 2024 | N/A | N/A | $109.73 | -$47.2 |
| Dec 2023 | 616.29 | N/A | $104.77 | $0.17 |
| Sep 2023 | N/A | N/A | $105.07 | -$0.14 |
| Jun 2023 | 377.94 | -63.23% | $128.5 | $0.34 |
| Mar 2023 | 1,027.82 | N/A | $174.73 | $0.17 |
| Dec 2022 | N/A | N/A | $166.21 | -$0.28 |
| Sep 2022 | N/A | N/A | $140.83 | -$0.75 |
| Jun 2022 | N/A | N/A | $203.94 | -$0.29 |
| Mar 2022 | 708 | 223.69% | $254.88 | $0.36 |
| Dec 2021 | 218.73 | -27.66% | $328.09 | $1.5 |
| Sep 2021 | 302.36 | -9.68% | $302.36 | $1 |
MLAB Price vs fair value
MLAB average PE ratio chart
MLAB PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| MMM 3M Co | 19.58 | $83.87B |
| TMO Thermo Fisher Scientific Inc | 25.45 | $164.16B |
| AME Ametek Inc | 29.57 | $41.78B |
| STE STERIS plc | 36.54 | $22.43B |
| GE General Electric Co | 39.42 | $272.38B |
| DHR Danaher Corp | 39.47 | $146.6B |
| BRKR Bruker Corp | 84.21 | $6.64B |
| HBIO Harvard Bioscience Inc | N/A | $19.66M |
| RMTI Rockwell Medical Inc | N/A | $38.62M |
| ANGO Angiodynamics Inc | N/A | $378.46M |
| MLAB Mesa Laboratories Inc | N/A | $471.46M |
Frequently asked questions
What is Mesa Laboratories's PE ratio?
The current price to earnings ratio of MLAB cannot be determined, as its EPS of -$0.36 is negative.
What is the 5-year average PE ratio for Mesa Laboratories (MLAB)?
The 5-year average price to earnings ratio for MLAB stock is 494.36.
What is the highest PE ratio for MLAB?
Over the last ten years, the Mar 2023 quarter recorded the highest quarterly PE ratio at 1,027.82.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.